What can you learn from this video analytics page?
This page shows views, likes, comments, RPM and revenue estimates, publish timing, topic tags, related videos, and the broader channel context behind the video.
テレ東BIZ ダイジェスト
@tvtokyobizSubscribers2.6M
Views2.6B
Videos55.4K
Last updated4 minutes ago
テレ東BIZ ダイジェストPublished at May 13, 2026 at 05:35 PM0:39
中央社会保険医療協議会がiPS細胞由来の再生医療製品「アムシェプリ」の公的医療保険適用を承認
24 days agoLong-tail
ipsshorts
Published time
May 13, 2026 at 05:35 PM
Duration
0:39
Video type
News & Politics
Channel region
Japan
Publish Timing Insight
Not enough timing data
This channel still lacks enough historical upload timing data. Let the channel accumulate more snapshots before evaluating the best timing.
Monetization Insight
No clear monetization tags yet
Focus on view growth, engagement quality, and topic competition to judge monetization potential.
Action Suggestion
Watch for sustained growth
The basic conditions are already in place. Keep watching 7-day views and revenue before deciding whether this topic should become a series.
Views
4.6K
Likes
54
Comments
7
Estimated Daily Revenue
-
Estimated Total Revenue
$0.11 - $0.44
RPM Range
$0.02 - $0.1
1D Views Gain
0
7D Views Gain
0
1D Likes Gain
0
7D Likes Gain
0
1D Comments Gain
0
7D Comments Gain
0
Velocity Score
0%
Topic Cluster
ips
Video Description
iPS細胞を使った製品として初めて保険の適用が承認されました。厚生労働大臣の諮問機関、中央社会保険医療協議会は、13日、iPS細胞由来の再生医療製品で初めてとなる、公的医療保険の適用を承認しました。承認されたのは、パーキンソン病を対象とした住友ファーマの「アムシェプリ」で、薬価は患者1人あたりおよそ5530万円です。iPS細胞を使った再生医療の実用化は世界初となる見通しです。
#厚生労働大臣 #諮問機関 #中央社会保険医療協議会 #iPS細胞 #再生医療製品 #アムシェプリ #公的医療保険 #適用 #承認
仕事や投資に役立つ経済メディア『テレ東BIZ』。
WBSやモーサテほか、他では見られない記者解説やオリジナル番組が充実
▼▼「テレ東BIZ」はこちら▼▼
https://txbiz.tv-tokyo.co.jp/lp/?utm_source=youtube&utm_medium=video
Related Topics
Continue with closely related videos to judge topic depth and content format.
Topic: ips
Not enough related-topic video data yet.
Video FAQs
These FAQs clarify what this video page measures, why revenue is estimated, and how to use the page for content research.
Why are RPM and revenue numbers estimates?
Actual earnings depend on monetized playbacks, audience geography, seasonality, advertiser demand, and monetization status. CloutOrbit provides directional estimates for benchmarking, not exact payouts.
How should you use this page for content research?
Compare timing, topic tags, monetization signals, and adjacent videos from the same channel to spot formats, themes, and publishing patterns worth testing.
Keep Exploring
Move from one video to the surrounding channel, trending market, sponsor landscape, and related topic searches.
Open the source channel
Review the channel-level growth, monetization, and similar creator context.
Explore trending videos
See which videos and Shorts are breaking out across the market right now.
Browse sponsor brands
Research brands that appear across adjacent creators and categories.
Search related topics
Use the current topic to discover similar videos and nearby content opportunities.